Octreotide Acetate
Product Images NDC 25021-464

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 25021-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Oct05 0003 01)

Chemical structure diagram of Octreotide Acetate showing its peptide sequence including amino acids such as D-Phe, Cys, Trp, Lys, Thr, and Phe, with an indication of variable acetate group count (x = 1.4 to 2.5).*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 02)

Label for Octreotide Acetate Injection, 1000 mcg per 5 mL (200 mcg per mL), a 5 mL multi-dose vial for subcutaneous injection. The label includes active ingredients and storage instructions, and identifies Sagent Pharmaceuticals as the manufacturer.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 03)

Label for Octreotide Acetate Injection, 5,000 mcg per 5 mL (1,000 mcg per mL) by Sagent Pharmaceuticals. The label indicates a 5 mL multi-dose vial for subcutaneous injection, listing active ingredient concentration and storage instructions. Includes NDC 25021-467-05 and manufacturer details.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 04)

Label for Octreotide Acetate Injection 50 mcg per mL, a 1 mL single-dose vial for subcutaneous injection. The label shows that the product is preservative-free, manufactured by Sagent Pharmaceuticals, and made in Canada. The NDC 25021-463-01 and barcode are visible on the label.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 05)

Label for Octreotide Acetate Injection 100 mcg per mL by Sagent Pharmaceuticals. The label indicates a 1 mL single-dose vial for subcutaneous injection. It is preservative-free, with instructions to discard unused portions. The label includes a barcode, lot, and expiration placeholders, and states the product is made in Canada.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Oct05 0003 06)

Label for Octreotide Acetate Injection, 500 mcg (base) per mL, in a 1 mL single-dose vial for subcutaneous injection. The product is preservative-free and manufactured for Sagent Pharmaceuticals. The label includes an NDC number, barcode, and indicates it is made in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.